Debrisoquine phenotype and genotype in Chinese.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  The Lancet

• Publication date

  1989-12-30

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/S0140-6736(89)92986-3PMID 2574814
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The distribution of debrisoquine metabolic phenotypes and implications for the suggested association with lung cancer risk

  1989cited by this paper
• Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

  1988cited by this paper

• Frequency of human CYP2D6 mutant alleles in a normal Chinese population

  2006cites this paper
• Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine

  2004cites this paper
• Genetic polymorphism of debrisoquine (CYP2D6) and proguanil (CYP2C19) in South Pacific Polynesian populations

  1998influential citation
• Frequency of human CYP2D6 mutant alleles in a normal Chinese population.

  1994cites this paper
• Distinct phenotypes and genotypes of debrisoquine hydroxylation among Europeans and Chinese.

  1991cites this paper
• Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls.

  1990cites this paper
• Lung cancer and the debrisoquine metabolic phenotype.

  1990cites this paper